Luisa Imberti

ORCID: 0000-0002-2075-8391
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • Immunodeficiency and Autoimmune Disorders
  • Immunotherapy and Immune Responses
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Monoclonal and Polyclonal Antibodies Research
  • Cytomegalovirus and herpesvirus research
  • Multiple Sclerosis Research Studies
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • HIV Research and Treatment
  • Polyomavirus and related diseases
  • Cancer Immunotherapy and Biomarkers
  • Chronic Lymphocytic Leukemia Research
  • COVID-19 and healthcare impacts
  • Diabetes and associated disorders
  • Systemic Lupus Erythematosus Research
  • vaccines and immunoinformatics approaches
  • Viral Infections and Immunology Research
  • Blood disorders and treatments
  • Cutaneous Melanoma Detection and Management
  • Full-Duplex Wireless Communications
  • Parvovirus B19 Infection Studies
  • Long-Term Effects of COVID-19

University of Brescia
2010-2025

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2015-2025

Research Institute Hospital 12 de Octubre
2024

University of South Florida
2022

Flinders Medical Centre
2022

Flinders University
2022

New York Medical College
1985-2015

Institute of Cell Biology and Neurobiology
2013

Inserm
2013

University of Münster
2013

Paul Bastard Lindsey B. Rosen Qian Zhang Eleftherios Michailidis Hans-Heinrich Hoffmann and 95 more Yu Zhang Karim Dorgham Quentin Philippot Jérémie Rosain Vivien Béziat Jérémy Manry Elana Shaw Liis Haljasmägi Pärt Peterson Lazaro Lorenzo Lucy Bizien Sophie Trouillet‐Assant Kerry Dobbs Adriana A. de Jesus Alexandre Bélot Anne Kallaste Émilie Catherinot Yacine Tandjaoui-Lambiotte Jérémie Le Pen Gaspard Kerner Benedetta Bigio Yoann Seeleuthner Rui Yang Alexandre Bolze András N. Spaan Ottavia M. Delmonte Michael S. Abers Alessandro Aiuti Giorgio Casari Vito Lampasona Lorenzo Piemonti Fabio Ciceri Kaya Bilgüvar Richard P. Lifton Marc Vasse David M. Smadja Mélanie Migaud Jérôme Hadjadj Benjamin Terrier Darragh Duffy Lluís Quintana‐Murci Diederik van de Beek Lucie Roussel Donald C. Vinh Stuart G. Tangye Filomeen Haerynck David Dalmau Javier Martínez‐Picado Petter Brodin Michel C. Nussenzweig Stéphanie Boisson‐Dupuis Carlos Rodríguez‐Gallego Guillaume Vogt Trine H. Mogensen Andrew J. Oler Jingwen Gu Peter D. Burbelo Jeffrey I. Cohen Andrea Biondi Laura Rachele Bettini Mariella D’Angiò Paolo Bonfanti Patrick Rossignol Julien Mayaux Frédéric Rieux‐Laucat Eystein S. Husebye Francesca Fusco Matilde Valeria Ursini Luisa Imberti Alessandra Sottini Simone Paghera Eugenia Quirós-Roldán Camillo Rossi Riccardo Castagnoli Daniela Montagna Amelia Licari Gian Luigi Marseglia Xavier Duval Jade Ghosn John S. Tsang Raphaela Goldbach‐Mansky Kai Kisand Michail S. Lionakis Anne Puel Shen‐Ying Zhang Steven M. Holland Guy Gorochov Emmanuelle Jouanguy Charles M. Rice Aurélie Cobat Luigi D. Notarangelo Laurent Abel Helen C. Su Jean‐Laurent Casanova Andrés A. Arias

Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 987 patients with life-threatening disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-ω (IFN-ω) (13 patients), 13 types IFN-α (36), or both (52) onset critical disease; a few also auto-Abs other three type I IFNs. The neutralize ability corresponding IFNs to block...

10.1126/science.abd4585 article EN cc-by Science 2020-09-24
Qian Zhang Paul Bastard Zhiyong Liu Jérémie Le Pen Marcela Moncada‐Vélez and 95 more Jie Chen Masato Ogishi Ira K. D. Sabli Stephanie Hodeib Cecilia B. Korol Jérémie Rosain Kaya Bilgüvar Junqiang Ye Alexandre Bolze Benedetta Bigio Rui Yang Andrés A. Arias Qinhua Zhou Yu Zhang Fanny Onodi Sarantis Korniotis Léa Karpf Quentin Philippot Marwa Chbihi Lucie Bonnet‐Madin Karim Dorgham Nikaïa Smith William M. Schneider Brandon S. Razooky Hans-Heinrich Hoffmann Eleftherios Michailidis Leen Moens Ji Eun Han Lazaro Lorenzo Lucy Bizien Philip Meade Anna‐Lena Neehus Aileen Camille Ugurbil Aurélien Corneau Gaspard Kerner Peng Zhang Franck Rapaport Yoann Seeleuthner Jérémy Manry Cécile Masson Yohann Schmitt Agatha Schlüter Tom Le Voyer Taushif Khan Juan Li Jacques Fellay Lucie Roussel Mohammad Shahrooei Mohammed F. Alosaimi Davood Mansouri Haya Al‐Saud Fahd Al‐Mulla Feras Almourfi Saleh Zaid Al-Muhsen Fahad Alsohime Saeed Al Turki Rana Hasanato Diederik van de Beek Andrea Biondi Laura Rachele Bettini Mariella D’Angiò Paolo Bonfanti Luisa Imberti Alessandra Sottini Simone Paghera Eugenia Quirós-Roldán Camillo Rossi Andrew J. Oler Miranda F. Tompkins Camille Alba Isabelle Vandernoot Jean‐Christophe Goffard Guillaume Smits Isabelle Migeotte Filomeen Haerynck Pere Soler‐Palacín Andrea Martín-Nalda Roger Colobrán Pierre‐Emmanuel Morange Sevgi Keleş Fatma Çölkesen Tayfun Özçelık Kadriye Kart Yaşar Sevtap Şenoğlu Şemsi̇ Nur Karabela Carlos Rodríguez‐Gallego Giuseppe Novelli Sami Hraiech Yacine Tandjaoui-Lambiotte Xavier Duval Cédric Laouénan Andrew L. Snow Clifton L. Dalgard Joshua D. Milner Donald C. Vinh

The genetics underlying severe COVID-19 immune system is complex and involves many genes, including those that encode cytokines known as interferons (IFNs). Individuals lack specific IFNs can be more susceptible to infectious diseases. Furthermore, the autoantibody dampens IFN response prevent damage from pathogen-induced inflammation. Two studies now examine likelihood affects risk of coronavirus disease 2019 (COVID-19) through components this (see Perspective by Beck Aksentijevich). Q....

10.1126/science.abd4570 article EN cc-by Science 2020-09-24
Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain Quentin Philippot and 95 more Jérémy Manry Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Boubacar Coulibaly Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Robert L. Nussbaum Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluís Quintana‐Murci Adam Klocperk

Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found about 10% patients with critical COVID-19 pneumonia, but not subjects asymptomatic infections. We detect auto-Abs 100-fold lower, more physiological, (100 pg/mL, 1/10 dilutions plasma) 13.6% 3,595 COVID-19, including 21% 374 > 80 years, and 6.5% 522 severe COVID-19. These antibodies also detected 18% the 1,124 deceased (aged 20 days-99 years; mean: 70...

10.1126/sciimmunol.abl4340 article EN cc-by Science Immunology 2021-08-10

Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contribute disease severity of 2019 (COVID-19). However, the utility specific immune-based biomarkers predict clinical outcome remains elusive. Here, we analyzed levels 66 soluble in 175 Italian patients with COVID-19 ranging from mild/moderate critical assessed type I IFN–, II NF-κB–dependent whole-blood transcriptional signatures. A broad signature was observed, implicating activation various...

10.1172/jci.insight.144455 article EN cc-by JCI Insight 2020-11-24

T cells are involved in the early identification and clearance of viral infections also support development antibodies by B cells. This central role for makes them a desirable target assessing immune response to SARS-CoV-2 infection. Here, we combined two high-throughput profiling methods create quantitative picture T-cell SARS-CoV-2. First, at individual level, deeply characterized 3 acutely infected 58 recovered COVID-19 subjects experimentally mapping their CD8 through antigen stimulation...

10.1101/2020.07.31.20165647 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-08-04

10.1038/s41591-022-01724-3 article EN Nature Medicine 2022-02-17
Jérémy Manry Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain and 95 more Quentin Philippot Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluís Quintana‐Murci Adam Klocperk Nelli Y. Kann Anna Shcherbina

Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It important to estimate their quantitative impact on mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence these risk death increase with higher in men. Using an unvaccinated sample 1,261 deceased patients 34,159 individuals from general population, we found against IFNs strongly increased...

10.1073/pnas.2200413119 article EN cc-by Proceedings of the National Academy of Sciences 2022-05-16
Tom Le Voyer Audrey V. Parent Xian Liu Axel Cederholm Adrian Gervais and 95 more Jérémie Rosain Tina Nguyen Malena Pérez Lorenzo Elze Rackaityte Darawan Rinchai Peng Zhang Lucy Bizien Gonca Hancıoğlu Pascale Ghillani‐Dalbin Jean‐Luc Charuel Quentin Philippot M Guèye Majistor Raj Luxman Maglorius Renkilaraj Masato Ogishi Camille Soudée Mélanie Migaud Flore Rozenberg Mana Momenilandi Quentin Riller Luisa Imberti Ottavia M. Delmonte Gabriele Müller Baerbel Keller Julio César Orrego William Alexander Franco Gallego Tamar Rubin Melike Emiroğlu Nima Parvaneh Daniel Eriksson Maribel Aranda‐Guillén David I. Berrios Linda Vong Constance H. Katelaris Peter Mustillo Johannes Raedler Jonathan Bohlen Jale Bengi Çelik Camila Astudillo Sarah Winter Stéphanie Boisson‐Dupuis Éric Oksenhendler Satoshi Okada Oana Caluseriu Mathilde Valeria Ursini Éric Ballot Geoffroy Lafarge Tomáš Freiberger Carlos A. Arango-Franco Romain Lévy Alessandro Aiuti Saleh Al‐Muhsen Fahd Al‐Mulla Evangelos Andreakos Andrés A. Arias Hagit Baris Feldman Paul Bastard Анастасія Бондаренко A. Borghesi Ahmed Aziz Bousfiha Petter Brodin Yenan T. Bryceson Giorgio Casari John Christodoulou Roger Colobrán Antonio Condino-Neto Jacques Fellay Carlos Flores José Luis Franco Filomeen Haerynck Rabih Halwani Lennart Hammarström James R. Heath Elena W.Y. Hsieh Yuval Itan Elżbieta Kaja Kai Kisand Cheng‐Lung Ku Yun Ling YL Lau Davood Mansouri Isabelle Meyts Joshua D. Milner Trine H. Mogensen Antonio Novelli Giuseppe Novelli Keisuke Okamoto Tayfun Özçelık Rebeca Pérez de Diego Jordi Pèrez‐Tur David S. Perlin Carolina Prando Aurora Pujol Lluís Quintana‐Murci Laurent Rénia Igor Resnick

Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal recessive AIRE deficiency produce autoantibodies that neutralize I interferons (IFNs)1,2, conferring a predisposition to life-threatening COVID-19 pneumonia3. Here we report patients NIK or RELB deficiency, specific of autosomal-dominant NF-κB2 also have neutralizing against IFNs and are at higher risk getting pneumonia. In these found only in individuals who heterozygous for variants associated both...

10.1038/s41586-023-06717-x article EN cc-by Nature 2023-11-08

Immune system aging is becoming a field of increasing public health interest because prolonged life expectancy, which not paralleled by an increase in expectancy. As age progresses, innate and adaptive immune systems undergo changes, are defined, respectively, as inflammaging senescence. A wealth available data demonstrates that these two conditions closely linked, leading to greater vulnerability elderly subjects viral, bacterial, opportunistic infections well lower post-vaccination...

10.3390/microorganisms12040775 article EN cc-by Microorganisms 2024-04-11

The mechanism of T cell depletion during infection with the human immunodeficiency virus (HIV) is unclear. Examination repertoire receptor V (variable) regions in persons infected HIV revealed absence a common set beta regions, whereas alpha usage was normal. lack these segments did not appear to correlate opportunistic infections. selective elimination cells that express defined sequences may indicate presence an HIV-encoded superantigen, similar those encoded by long terminal repeat mouse...

10.1126/science.1948066 article EN Science 1991-11-08

Abstract Synovial fluids of patients with rheumatoid arthritis contain activated T lymphocytes that may play an important role in the pathogenesis disease. Previous studies have suggested cell receptor (TcR) repertoire these cells is restricted, reflecting vivo selection a limited number specificities at site inflammation. To characterize better populations we used polymerase chain reaction technology to estimate proportion TcR α and β RNA containing any particular V elements from...

10.1002/eji.1830210231 article EN European Journal of Immunology 1991-02-01

Altered glomerular metabolism of arachidonic acid (AA) has already been demonstrated in experimental nephrotoxic nephritis. The enhanced synthesis thromboxane A2 (TxA2) isolated glomeruli that found may mediate changes renal hemodynamics. objectives this investigation were: to check whether AA is also altered a model glomerulopathy which no leukocyte infiltration or platelet deposition could be demonstrated; establish correlation between the and proteinuria; explore alteration prostaglandin...

10.1172/jci111703 article EN Journal of Clinical Investigation 1985-01-01

To find biomarkers identifying patients at risk for the development of progressive multifocal leukoencephalopathy (PML) during natalizumab treatment.Patients were recruited from 10 European and US cohorts. Of 289 with multiple sclerosis (MS), 224 had been treated (18-80 months), 21 received other immune-modulatory treatments, 28 untreated. We access to samples 16 PML patients. Eight these given blood before diagnosis PML. also analyzed non-natalizumab-treated who developed (n = 10) age-...

10.1212/wnl.0b013e3182a351fb article EN Neurology 2013-08-08

Type-I interferons (IFNs) mediate antiviral activity and have emerged as important immune mediators during coronavirus disease 19 (COVID-19). Several lines of evidence suggest that impaired type-I IFN signaling may predispose to severe COVID-19. However, the pathophysiologic mechanisms contribute illness severity remain unclear. In this study, our goal was gain insight into how IFNs influence outcomes in patients with To achieve goal, we compared clinical between 26 neutralizing...

10.1111/imcb.12495 article EN Immunology and Cell Biology 2021-07-26

The thymus plays a fundamental role in establishing and maintaining central peripheral tolerance defects thymic architecture or AIRE expression result the development of autoreactive lymphocytes. Patients with partial DiGeorge Syndrome (DGS) Down (DS) present alterations size higher risk to develop autoimmunity. We sought evaluate thymocyte DGS DS patients determine extent which immune dysregulation T cell homeostasis perturbation these patients. Thymi from pediatric age-matched controls...

10.3389/fimmu.2019.00447 article EN cc-by Frontiers in Immunology 2019-03-15
Paul Bastard Sara E. Vazquez Jamin Liu Matthew T. Laurie Chung‐Yu Wang and 95 more Adrian Gervais Tom Le Voyer Lucy Bizien Colin R. Zamecnik Quentin Philippot Jérémie Rosain Émilie Catherinot Andrew Willmore Anthea Mitchell Rebecca Bair Pierre Garçon Heather Kenney Arnaud Fekkar Maria Salagianni Garyphallia Poulakou Eleni Siouti Sabina Sahanic Ivan Tancevski Günter Weiß Laurenz Nagl Jérémy Manry Sotiriјa Duvlis Daniel Arroyo‐Sánchez Estela Paz‐Artal Luis Rubio Cristiano Perani Michela Bezzi Alessandra Sottini Virginia Quaresima Lucie Roussel Donald C. Vinh Luis Felipe Reyes Margaux Garzaro Nevin Hatipoğlu David Boutboul Yacine Tandjaoui-Lambiotte A. Borghesi Anna Aliberti Irene Cassaniti Fabienne Venet Guillaume Monneret Rabih Halwani Narjes Saheb Sharif‐Askari Jeffrey J. Danielson Sonia Burrel Caroline Morbieu Yuriy Stepanovskyy Анастасія Бондаренко Алла Волоха Oksana Boyarchuk Alenka Gagro Mathilde Neuville Bénédicte Neven Sevgi Keleş Romain Hernu Antonin Bal Antonio Novelli Giuseppe Novelli Kahina Saker Oana Ailioaie Arnau Antolí Éric Jeziorski Gemma Rocamora-Blanch Carla Teixeira Clarisse Delaunay Marine Lhuillier Paul Le Turnier Yu Zhang Matthieu Mahévas Qiang Pan‐Hammarström Hassan Abolhassani Thierry Bompoil Karim Dorgham Guy Gorochov Cédric Laouénan Carlos Rodríguez‐Gallego Lisa F. P. Ng Laurent Rénia Aurora Pujol Alexandre Bélot F. Raffi Luís M. Allende Javier Martínez‐Picado Tayfun Özçelık Luisa Imberti Luigi D. Notarangelo Jesús Troya Xavier Solanich Shen‐Ying Zhang Anne Puel Michael R. Wilson Sophie Trouillet‐Assant Laurent Abel Emmanuelle Jouanguy Chun Ye

Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning antibody (Ab) response SARS-CoV-2 vaccines in individuals already at risk. Preexisting auto-Abs neutralizing type I IFNs underlie least 15% pneumonia unvaccinated individuals; their contribution hypoxemic breakthrough vaccinated people is unknown. We studied a cohort 48 (aged 20 86 years) who received two doses messenger RNA (mRNA) vaccine and developed infection with 2 weeks 4 months later. Ab levels...

10.1126/sciimmunol.abp8966 article EN cc-by Science Immunology 2022-06-14

Abstract Combination of chemotherapy with cancer vaccines is currently regarded as a potentially valuable therapeutic approach for the treatment some metastatic tumors, but optimal modalities remain unknown. We designed phase I/II pilot study evaluating effects dacarbazine (DTIC) on immune response in HLA‐A2 + disease‐free melanoma patients who received anticancer vaccination 1 day following (800 mg/mq i.v.). The vaccine, consisting combination restricted antigen A (Melan‐A/MART‐1) and gp100...

10.1002/ijc.23886 article EN International Journal of Cancer 2008-10-06
Coming Soon ...